← All Sponsors
SPONSOR

University of Rochester

Total Trials
12
Recruiting
12
Phases
Phase 1, Phase 3, Phase 2

University of Rochester is a clinical research sponsor with 12 registered studies on ClinicalTrials.gov, of which 12 are actively recruiting participants. Research covers conditions including Basal Cell Carcinoma, Lung Cancer, Non-small Cell Lung Cancer, Cancer.

The trial portfolio spans Phase 1, Phase 3, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University of Rochester

How many clinical trials has University of Rochester sponsored?
ClinicalMetric currently tracks 12 clinical trials sponsored by University of Rochester, of which 12 are actively recruiting participants. These trials cover conditions including Basal Cell Carcinoma, Lung Cancer, Non-small Cell Lung Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Rochester research focus on?
University of Rochester clinical trials span Basal Cell Carcinoma, Lung Cancer, Non-small Cell Lung Cancer, Cancer, Breathing, Mouth, and additional conditions. The research pipeline includes Phase 1, Phase 3, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Rochester clinical trial?
To participate in a University of Rochester trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Rochester trials with current recruitment status updated daily.

Clinical Trials by University of Rochester

NCT06473103
Recruiting

Investigation of Standard Excision Surgical Margins Using Two Photon Fluorescence Microscopy

Basal Cell Carcinoma
NCT03706027
Recruiting

Study Comparing Two Different Schedules of Radiation for Early-stage Lung Cancer

Lung Cancer
NCT04297605 Phase 1
Recruiting

Study of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2

Non-small Cell Lung Cancer
NCT07390045
Recruiting

Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors

Cancer
NCT06554353
Recruiting

Cardiopulmonary Exercise Testing and Oscillometry for the Evaluation of Dyspnea

Breathing, Mouth
NCT07071207
Recruiting

Effect of Text Message Reminders on M-ISI Score After Prostate Surgery

Incontinence, Urinary Stress
NCT05838716 Phase 3
Recruiting

Vitamin D for Prostate Endocrine Therapy

Stage I Prostate Cancer AJCC v8
NCT06319872 Phase 1
Recruiting

The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration

Alcohol Use Disorder
NCT03758989 Phase 2
Recruiting

A Study of PET Adapted Therapy and Non-invasive Monitoring for Previously Untreated Limited Stage Diffuse Large B Cell Lymphoma

DLBCL
NCT05272254 Phase 2
Recruiting

Povidone Iodine Efficacy Study

Early Childhood Caries
NCT05006482 Phase 3
Recruiting

Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial

Lymphoma
NCT06073431
Recruiting

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

Advanced Colorectal Carcinoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology